Effect of the β‐glucuronidase inhibitor saccharolactone on glucuronidation by human tissue microsomes and recombinant UDP‐glucuronosyltransferases

No abstract is available for this paper.

• Publication year

  2008

• Venue

  The Journal of pharmacy and pharmacology

• Publication date

  2008-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1211/jpp.60.9.0009PMID 18718121PMCID PMC2697495
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In Vitro Studies in Microsomes from Rat and Human Liver, Kidney, and Intestine Suggest That Perfluorooctanoic Acid Is Not a Substrate for Microsomal UDP-Glucuronosyltransferases

  2005cited by this paper
• UDP Glucuronosyltransferase (UGT) 1A6 Pharmacogenetics: I. Identification of Polymorphisms in the 5′-Regulatory and Exon 1 Regions, and Association with Human Liver UGT1A6 Gene Expression and Glucuronidation

  2005cited by this paper
• Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases.

  2005cited by this paper
• Differential and Special Properties of the Major Human UGT1-encoded Gastrointestinal UDP-glucuronosyltransferases Enhance Potential to Control Chemical Uptake*

  2004influential reference
• Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism.

  2003cited by this paper
• Validation of serotonin (5-hydroxtryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6.

  2003cited by this paper
• The effect of incubation conditions on the enzyme kinetics of udp-glucuronosyltransferases.

  2003cited by this paper
• Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTs): S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9.

  2002cited by this paper
• In vitro-in vivo correlations for drugs eliminated by glucuronidation: investigations with the model substrate zidovudine.

  2002influential reference
• Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance.

  2002cited by this paper
• Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearance.

  2002cited by this paper
• High-performance liquid chromatographic assay for acetaminophen glucuronide in human liver microsomes.

  2001influential reference
• In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin.

  2000cited by this paper
• Human UDP-glucuronosyltransferases: metabolism, expression, and disease.

  2000cited by this paper
• Molecular basis for deficient acetaminophen glucuronidation in cats. An interspecies comparison of enzyme kinetics in liver microsomes.

  1997cited by this paper
• Conjugation-deconjugation cycling of diflunisal via beta-glucuronidase catalyzed hydrolysis of its acyl glucuronide in the rat.

  1997cited by this paper
• STRUCTURE AND FUNCTION OF URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASES

  1997cited by this paper
• Glucuronidation of SN-38, the active metabolite of irinotecan, by human hepatic microsomes.

  1997cited by this paper
• Glucuronidation of diflunisal in liver and kidney microsomes of rat and man.

  1996cited by this paper
• Glucuronidation of diflunisal by rat liver microsomes. Effect of microsomal beta-glucuronidase activity.

  1993influential reference
• Glucuronidation and its role in regulation of biological activity of drugs.

  1992cited by this paper
• Drug glucuronidation in humans.

  1991cited by this paper
• Mammalian beta-glucuronidase: genetics, molecular biology, and cell biology.

  1989cited by this paper
• Changes in translational yield regulate tissue-specific expression of beta-glucuronidase.

  1987cited by this paper
• The egasyn gene affects the processing of oligosaccharides of lysosomal beta-glucuronidase in liver.

  1986cited by this paper
• Interference of UDP-glucuronyltransferase and beta-glucuronidase activity in rat liver microsomes at pH 7.5 with p-nitrophenol and p-nitrophenylglucuronide as substrates.

  1979cited by this paper
• Interference of UDP-glucuronyltransferase and beta-glucuronidase activity in rat liver microsomes at pH 7.5 with p-nitrophenol and p-nitrophenylglucuronide as substrates.

  1979cited by this paper
• β-GLUCURONIDASES IN METABOLIC HYDROLYSIS

  1970cited by this paper
• Glucuronide Decomposition in the Digestive Tract

  1952cited by this paper
• The preparation and properties of β-glucuronidase. 4. Inhibition by sugar acids and their lactones

  1952cited by this paper
• The preparation and properties of beta-glucuronidase. IV. Inhibition by sugar acids and their lactones.

  1952cited by this paper

• UDP-Glucuronosyl transferase mediated drug-drug interactions: An Industry perspective on recommended in vitro studies.

  2026cites this paper
• Nano micelle mediated In-Vitro release kinetics of two Biopharmaceutical Classification System (BCS) class II drugs with varying hydrophobicity

  2025cites this paper
• Effect of Saccharolactone on CYP-mediated metabolism of Xenobiotics.

  2023cites this paper
• Species differences in liver microsomal hydrolysis of acyl glucuronide in humans and rats

  2022cites this paper
• Identification and Quantification of MIDD0301 metabolites.

  2021cites this paper
• Enzyme Kinetics of Uridine Diphosphate Glucuronosyltransferases (UGTs).

  2021cites this paper
• Beta-Glucuronidase Inhibition by Constituents of Mulberry Bark

  2021cites this paper
• β-Glucuronidase inhibitors from Malaysian plants

  2020cites this paper
• Evidence-based strategies for the characterisation of human drug and chemical glucuronidation in vitro and UDP-glucuronosyltransferase reaction phenotyping.

  2020cites this paper
• In vitro and in vivo studies of triacetone triperoxide (TATP) metabolism in humans

  2020cites this paper
• New Benzamide Analogues of Metronidazole‐tethered Triazoles as Non‐sugar Based Inhibitors of β ‐Glucuronidase

  2019cites this paper
• Carbazole‐Linked 1,2,3‐Triazoles: In Vitro β ‐Glucuronidase Inhibitory Potential, Kinetics, and Molecular Docking Studies

  2019cites this paper
• Major glucuronide metabolites of testosterone are primarily transported by MRP2 and MRP3 in human liver, intestine and kidney.

  2019cites this paper
• Critical Differences between Enzyme Sources in Sensitivity to Detect Time-Dependent Inactivation of CYP2C8

  2019cites this paper
• Bioinformatics: A rational combine approach used for the identification and in-vitro activity evaluation of potent β-Glucuronidase inhibitors

  2018cites this paper
• Isogloiosiphone B, a novel acetal, and hydrophobic compounds as β-glucuronidase inhibitors derived from the red alga Neodilsea yendoana

  2018cites this paper
• Hepatic Transport of 25-Hydroxyvitamin D3 Conjugates: A Mechanism of 25-Hydroxyvitamin D3 Delivery to the Intestinal Tract

  2018cites this paper
• Physiologically based kinetic modeling of hesperidin metabolism and its use to predict in vivo effective doses in humans.

  2017cites this paper
• Microbiota and Breast Cancer.

  2017cites this paper
• In vitro‐in silico‐based analysis of the dose‐dependent in vivo oestrogenicity of the soy phytoestrogen genistein in humans

  2017cites this paper
• Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance

  2016cites this paper
• Structural insights into ?-glucuronidase inhibition to mitigate camptothecin chemoterapeutics side effects

  2015cites this paper
• Chemoenzymatic Synthesis, Characterization, and Scale-Up of Milk Thistle Flavonolignan Glucuronides

  2015cites this paper
• Screening of non-steroidal anti-inflammatory drugs for inhibitory effects on the activities of six UDP-glucuronosyltransferases (UGT1A1, 1A3, 1A4, 1A6, 1A9 and 2B7) using LC-MS/MS.

  2015cites this paper
• Phase II Metabolism in Human Skin: Skin Explants Show Full Coverage for Glucuronidation, Sulfation, N-Acetylation, Catechol Methylation, and Glutathione Conjugation

  2015cites this paper
• Xenobiotic and non-xenobiotic interventions in the microbiome therapeutics.

  2015cites this paper
• Simultaneous Screening of Activities of Five Cytochrome P450 and Four Uridine 5′-Diphospho-glucuronosyltransferase Enzymes in Human Liver Microsomes Using Cocktail Incubation and Liquid Chromatography–Tandem Mass Spectrometry

  2015cites this paper
• Selective induction of hepatic cytochrome P450 2B activity by leelamine in vivo, as a potent novel inducer

  2015cites this paper
• Accurate identification of UDP-glucuronosyltransferase 1A1 (UGT1A1) inhibitors using UGT1A1-overexpressing HeLa cells

  2015cites this paper
• Special Section on Drug Metabolism and the Microbiome—Minireview Investigation of Host–Gut Microbiota Modulation of Therapeutic Outcome

  2015cites this paper
• Reaction Phenotyping: Advances in the Experimental Strategies Used to Characterize the Contribution of Drug-Metabolizing Enzymes

  2015cites this paper
• Synthesis of novel benzohydrazone-oxadiazole hybrids as β-glucuronidase inhibitors and molecular modeling studies.

  2015cites this paper
• DMD063016 1137..1146

  2015cites this paper
• DMD063750 1619..1631

  2015cites this paper
• Simultaneous Screening of Activities of Five Cytochrome P450 and Four Uridine 5'- Diphospho-glucuronosyltransferase Enzymes in Human Liver Microsomes Using Cocktail Incubation and Liquid Chromatography-Tandem Mass Spectrometry

  2015cites this paper
• Screening of six UGT enzyme activities in human liver microsomes using liquid chromatography/triple quadrupole mass spectrometry.

  2014cites this paper
• Human UGT1A4 and UGT1A3 conjugate 25-hydroxyvitamin D3: metabolite structure, kinetics, inducibility, and interindividual variability.

  2014cites this paper
• Confounding factors and genetic polymorphism in the evaluation of individual steroid profiling

  2014cites this paper
• DMD060350 126..139

  2014cites this paper
• Metabolism of a novel skepinone L-like p38 mitogen-activated protein kinase inhibitor

  2014cites this paper
• Natural variations in xenobiotic-metabolizing enzymes: developing tools for coral monitoring

  2014cites this paper
• Selective induction of hepatic cytochrome P450 2B activity by leelamine in vivo, as a potent novel inducer

  2014cites this paper
• Enzyme kinetics of uridine diphosphate glucuronosyltransferases (UGTs).

  2014cites this paper
• Glukuronidtranszport az endoplazmás retikulumban

  2014cites this paper
• The role of drug metabolizing enzymes in clearance

  2014cites this paper
• Overestimation of flavonoid aglycones as a result of the ex vivo deconjugation of glucuronides by the tissue β-glucuronidase.

  2014cites this paper
• Luminal accumulation of newly synthesized morphine-3-glucuronide in rat liver microsomal vesicles.

  2013cites this paper
• Rapid estrogenic signaling activities of the modified (chlorinated, sulfonated, and glucuronidated) endocrine disruptor bisphenol A

  2013cites this paper
• Activity and Enzyme Kinetics of Human UDP-Glucuronosyltransferases : Studies of Psilocin Glucuronidation and the Effects of Albumin on the Enzyme Kinetic Mechanism

  2013cites this paper
• In vitro assessment of some traditional medications used in South Africa for pharmacokinetics drug interaction potential

  2013cites this paper
• Pharmacologic Targeting of Bacterial β-Glucuronidase Alleviates Nonsteroidal Anti-Inflammatory Drug-Induced Enteropathy in Mice

  2012cites this paper
• Optimized Assays for Human UDP-Glucuronosyltransferase (UGT) Activities: Altered Alamethicin Concentration and Utility to Screen for UGT Inhibitors

  2012cites this paper
• Methods for Determination of Enzyme Kinetics and Metabolic Rates

  2012cites this paper
• UDP‐Glucuronosyltransferases: Pharmacogenetics, Functional Characterization, and Clinical Relevance

  2012cites this paper
• In vitro interaction of a novel neutrophil growth factor with human liver microsomal cytochromes P450 and the contribution of UDP-glucuronosyltransferases to its metabolism

  2011cites this paper
• Phenylalanine 93 of the human UGT1A10 plays a major role in the interactions of the enzyme with estrogens.

  2011cites this paper
• Drug Metabolizing Enzymes

  2011cites this paper
• Understanding Human Drug Conjugating Enzymes; Regio- and Stereoselectivity in Sulfotransferase 1A3 and the UDP-Glucuronosyltransferases

  2011cites this paper
• Characterization of Inhibitory Effect of Carbapenem Antibiotics on the Deconjugation of Valproic Acid Glucuronide

  2010influential citation
• Microsoft Word-16561826-file00

  2010cites this paper
• Stereoselectivity of the Human UDP-glucuronosyltransferases : Studies on Androgens and Propranolol Glucuronidation

  2010cites this paper
• The In Vitro Characterization of Inhibitory Drug–Drug Interactions Involving UDP-Glucuronosyltransferase

  2010cites this paper
• N-Glucuronidation of Drugs and Other Xenobiotics

  2010cites this paper
• The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro–in vivo extrapolation of drug clearance and drug-drug interaction potential

  2010cites this paper
• The Role of Human UDP-glucuronyltransferases on the Formation of the Methylenedioxymethamphetamine (Ecstasy) Phase II Metabolites R - and S -3-methoxymethamphetamine 4- O -glucuronides

  2009cites this paper
• The Role of Human UDP-Glucuronyltransferases on the Formation of the Methylenedioxymethamphetamine (Ecstasy) Phase II Metabolites R- and S-3-Methoxymethamphetamine 4-O-Glucuronides

  2009cites this paper
• Special Section on Transporters in Drug Disposition and Pharmacokinetic Prediction Hepatic Transport of 25-Hydroxyvitamin D 3 Conjugates: A Mechanism of 25-Hydroxyvitamin D 3 Delivery to the Intestinal Tract

  year unknowncites this paper